Dong Yuanli, Guan Hui, Huang Wei, Zhang Zicheng, Zhao Dongbo, Liu Yang, Zhou Tao, Li Baosheng
1 Department of Radiation Oncology (Chest Section), Shandong's Key Laboratory of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong Academy of Medical Sciences, Jinan 250117, China ; 2 School of Medicine and Life Sciences, University of Jinan and Shandong Academy of Medical Sciences, Jinan 250117, China ; 3 Department of Thoracic Surgical Oncology, Shandong Cancer Hospital and Institute, Shandong Academy of Medical Sciences, Jinan 250117, China.
J Thorac Dis. 2015 Dec;7(12):2313-20. doi: 10.3978/j.issn.2072-1439.2015.12.10.
This work aims to investigate lymph node metastases (LNM) pattern of crossing-segments thoracic esophageal squamous cell carcinoma (ESCC) and its significance in clinical target volume (CTV) delineation.
From January 2000 to December 2014, 3,587 patients with thoracic ESCC underwent surgery including esophagectomy and lymphadenectomy at Shandong Cancer Hospital and Institute. Information of tumor location based on preoperative endoscopic ultrasonography (EUS) and postoperative pathological results were retrospectively collected. The extent of the irradiation field was determined based on LNM pattern.
Among the patients reviewed, 1,501 (41.8%) were crossing-segments thoracic ESCC patients. The rate of LNM were 12.1%, 15.2%, 8.0%, 3.0%, and 7.1% in neck, upper mediastinum, middle mediastinum, lower mediastinum, and abdominal cavity for patients with upper-middle thoracic ESCC, 10.3%, 8.2%, 11.0%, 4.8%, 8.2% for middle-upper thoracic ESCC, 4.8%, 4.8%, 24.1%, 6.3%, 22.8% for middle-lower thoracic ESCC and 3.9%, 3.1%, 22.8%, 11.9%, 25.8% for lower-middle thoracic ESCC, respectively. The top three sites of LNM were 105 (12.1%), 108 (6.1%), 101 (6.1%) for upper-middle thoracic ESCC, 108 (8.2%), 105 (7.5%), 106 (6.8%) for middle-upper thoracic ESCC, 1 (18.8%), 108 (17.9%), 107 (9.6%) for middle-lower thoracic ESCC, 1 (21.3%), 108 (16.1%), 107 (10.1%) for lower-middle thoracic ESCC.
Crossing-segments thoracic ESCC was remarkably common among patients. When delineating their CTV, tumor location should be taken into consideration seriously. For upper-middle and middle-upper thoracic ESCC, abdominal cavity may be free from irradiation. For middle-lower and lower-middle thoracic ESCC, besides irradiation of relative mediastinal, irradiation of abdominal cavity can't be neglected.
本研究旨在探讨跨段胸段食管鳞状细胞癌(ESCC)的淋巴结转移(LNM)模式及其在临床靶区(CTV)勾画中的意义。
2000年1月至2014年12月,3587例胸段ESCC患者在山东省肿瘤医院和研究所接受了包括食管切除术和淋巴结清扫术在内的手术。回顾性收集基于术前超声内镜检查(EUS)的肿瘤位置信息和术后病理结果。根据LNM模式确定照射野范围。
在纳入研究的患者中,1501例(41.8%)为跨段胸段ESCC患者。上中胸段ESCC患者颈部、上纵隔、中纵隔、下纵隔和腹腔的LNM发生率分别为12.1%、15.2%、8.0%、3.0%和7.1%;中上前胸段ESCC患者分别为10.3%、8.2%、11.0%、4.8%和8.2%;中下胸段ESCC患者分别为4.8%、4.8%、24.1%、6.3%和22.8%;下中胸段ESCC患者分别为3.9%、3.1%、22.8%、11.9%和25.8%。上中胸段ESCC的前三位LNM部位分别为105(12.1%)、108(6.1%)、101(6.1%);中上前胸段ESCC分别为108(8.2%)、105(7.5%)、106(6.8%);中下胸段ESCC分别为1(18.8%)、108(17.9%)、107(9.6%);下中胸段ESCC分别为1(21.3%)、108(16.1%)、107(10.1%)。
跨段胸段ESCC在患者中非常常见。在勾画其CTV时,应认真考虑肿瘤位置。对于上中胸段和中上前胸段ESCC,腹腔可能无需照射。对于中下胸段和下中胸段ESCC,除了照射相关纵隔外,腹腔照射也不容忽视。